Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.

Wright CH, Wright J, Cioffi G, Hdeib A, Kasliwal MK, Kruchko C, Barnholtz-Sloan JS, Sloan AE.

J Neurosurg Spine. 2019 Nov 1:1-10. doi: 10.3171/2019.7.SPINE19566. [Epub ahead of print]

PMID:
31675723
2.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Nov 1;21(Supplement_5):v1-v100. doi: 10.1093/neuonc/noz150.

PMID:
31675094
3.

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.

Gittleman H, Cioffi G, Chunduru P, Molinaro AM, Berger MS, Sloan AE, Barnholtz-Sloan JS.

Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.

4.

Survival in Patients with High-Grade Spinal Meningioma: An Analysis of the National Cancer Database.

Wright JM, Wright CH, Cioffi G, Raghavan A, Hdeib A, Kasliwal MK, Kruchko C, Barnholtz-Sloan JS, Sloan AE.

World Neurosurg. 2019 Sep;129:e749-e753. doi: 10.1016/j.wneu.2019.06.015. Epub 2019 Jun 14.

PMID:
31203074
5.

Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.

Gittleman H, Cioffi G, Vecchione-Koval T, Ostrom QT, Kruchko C, Osorio DS, Finlay JL, Barnholtz-Sloan JS.

J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.

PMID:
31025275

Supplemental Content

Loading ...
Support Center